Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
- PMID: 17283112
- DOI: 10.1158/0008-5472.CAN-06-4744
Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
Abstract
Hypoxia-inducible factor-1 (HIF-1) stabilization is a pivotal event in the response to hypoxic stress. A study in the December 15, 2006 issue of Cancer Research shows that HIF-1 stabilization occurs more robustly as a result of intermittent hypoxia compared with chronic hypoxia. The findings of this study suggest that intermittent hypoxia might influence the efficacy of radiotherapy by more strongly affecting the growth and survival of vascular endothelial cells. This finding offers additional encouragement to efforts to target HIF-1 for cancer therapy.
Comment on
-
Endothelins induce CCR7 expression by breast tumor cells via endothelin receptor A and hypoxia-inducible factor-1.Cancer Res. 2006 Dec 15;66(24):11802-7. doi: 10.1158/0008-5472.CAN-06-1222. Cancer Res. 2006. PMID: 17178876
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
